Marksans Pharma Ltd
BSE:524404
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Marksans Pharma Ltd
BSE:524404
|
IN |
|
Sembcorp Marine Ltd
SGX:S51
|
SG |
|
M
|
Monnalisa SpA
MIL:MNL
|
IT |
|
EDM Resources Inc
OTC:EDMFF
|
CA |
|
Powercell Sweden AB (publ)
STO:PCELL
|
SE |
|
A
|
Abacus Mining and Exploration Corp
OTC:ABCFF
|
CA |
|
Vinte Viviendas Integrales SAB de CV
OTC:VNTEF
|
MX |
|
B
|
Babcock International Group PLC
DUS:BW3
|
UK |
|
Sonic Healthcare Ltd
ASX:SHL
|
AU |
|
A
|
Arras Minerals Corp.
OTC:ARRKF
|
CA |
Wall St Price Targets
MARKSANS Price Targets Summary
Marksans Pharma Ltd
According to Wall Street analysts, the average 1-year price target for MARKSANS is 229.13 INR with a low forecast of 211.76 INR and a high forecast of 251.6 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MARKSANS's stock price target?
Price Target
229.13
INR
According to Wall Street analysts, the average 1-year price target for MARKSANS is 229.13 INR with a low forecast of 211.76 INR and a high forecast of 251.6 INR.
What is the Revenue forecast for Marksans Pharma Ltd?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 4 years is 16%.
What is the Operating Income forecast for Marksans Pharma Ltd?
Projected CAGR
23%
The compound annual growth rate for Operating Income over the next 4 years is 23%.
What is the Net Income forecast for Marksans Pharma Ltd?
Projected CAGR
20%
The compound annual growth rate for Net Income over the next 4 years is 20%.
